Pilocytic astrocytoma
ICD-10 C71.9 · ICD-11 2A00.0Y&XH29Q5

Treatment of Pilocytic Astrocytoma in Patients Aged 18 Years or Older

Pilocytic astrocytoma is a CNS WHO grade 1 tumor. In adult patients aged 18 years or older, the therapeutic focus is on achieving durable local tumor control — and, when seizures are present, freedom from seizures.

Clinical Scenario

This protocol applies specifically to patients aged 18 years or older with a diagnosis of pilocytic astrocytoma.

Treatment Approach (partial overview)

Management centres on a surgical strategy that prioritises the most complete tumor removal the anatomy will allow, with the extent of resection directly influencing long-term outcomes. The full protocol — including the complete decision algorithm and all clinical considerations — is accessible below.

Treatment Goals
Instant Access to Structured Evidence-Based Regimens
References

DOI: 10.1093/neuonc/noac188

Gross total resection, when feasible, is the most important treatment in terms of prolonging survival and achieving long-term seizure control.

Resection is recommended to obtain a histological and molecular diagnosis and should be a gross total resection whenever feasible.

Gross total resection for well-circumscribed CNS WHO grade 1 tumors can produce long-term tumor control and even cure.

Early operative intervention and gross-total resection are critically important factors in achieving seizure-freedom and should be proposed in patients presenting with seizures.

View source ↗